Kornitzer Capital Management’s Revolution Medicines RVMD Stock Holding History

Kornitzer Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.17M	Buy	+16,947	New	+$2.48M	0.07%	252

Other funds holding RVMD

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Kornitzer Capital Management's RVMD Position: Q2 2026 in Review

Kornitzer Capital Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 16,947 shares worth $3.17M. The stake represents 0.07% of the portfolio and ranks #252 among its holdings.

199 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Kornitzer Capital Management held 16,947 shares of Revolution Medicines worth $3.17M as of Q2 2026.
Revolution Medicines was a new Kornitzer Capital Management position in Q2 2026.
Revolution Medicines made up 0.07% of Kornitzer Capital Management's portfolio in Q2 2026, its #252 holding.
199 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.